Verrica Pharmaceuticals Inc. (VRCA)
VRCA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.58
-10.72% on the day
Market cap
$61.5M
Micro cap
Revenue · 2025
$35.6M
+370.2% on 2024
Net income · 2025
-$17.9M
-50.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | VRCA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001660334 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $35.6M |
| Net income | -$17.9M |
| Operating income | -$12.2M |
| Net margin | -50.3% |
| Operating margin | -34.2% |
| Revenue growth | +370.2% |
| Cash | $30.1M |
| Total assets | $47.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2025-12-23 |
| Latest annual report | 10-K | 2026-03-11 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-20 |
Source: SEC EDGAR submissions feed, 534 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GANX | Gain Therapeutics Inc. | $1.41 | -10.19% | $61.5M |
| APLM | Apollomics Inc. | $21.32 | 0.00% | $61.7M |
| XLO | Xilio Therapeutics Inc. | $9.22 | +1.60% | $60.7M |
| PLRX | Pliant Therapeutics Inc. | $0.9680 | -1.83% | $59.9M |
| TENX | Tenax Therapeutics Inc. | $1.60 | -12.57% | $59.9M |
| GOSS | Gossamer Bio Inc. | $9.76 | +5.17% | $59.7M |
| ONCY | Oncolytics Biotech Inc. | $0.4900 | +3.53% | $64.2M |
| SDEV | Stablecoin Development Corporation | $1.25 | -11.35% | $64.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier